Surgical Innovations Group plc (AIM:SUN)
London
· Delayed Price · Currency is GBP · Price in GBX 0.5500
+0.0250 (4.76%)
Apr 25, 2025, 4:35 PM GMT+1
AIM:SUN Revenue
Surgical Innovations Group had revenue of 6.18M GBP in the half year ending June 30, 2024, with 14.08% growth. This brings the company's revenue in the last twelve months to 12.54M, up 8.31% year-over-year. In the year 2023, Surgical Innovations Group had annual revenue of 12.01M with 5.94% growth.
Revenue (ttm)
12.54M
Revenue Growth
+8.31%
P/S Ratio
0.39
Revenue / Employee
156.74K
Employees
101
Market Cap
4.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12.01M | 674.00K | 5.94% |
| Dec 31, 2022 | 11.34M | 2.21M | 24.26% |
| Dec 31, 2021 | 9.13M | 2.80M | 44.19% |
| Dec 31, 2020 | 6.33M | -4.40M | -41.03% |
| Dec 31, 2019 | 10.73M | -236.00K | -2.15% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Surgical Innovations Group News
- 2 months ago - AIM Market Roundup: Gelion, Surgical Innovations, Deltex Medical - The Armchair Trader